THE STORY

A better answer to accelerated ageing

A2P2 began with a simple scientific objection: a universal Q₁₀ assumption cannot describe every polymer, processing history, sterilisation route and failure mechanism.

Dr Nazli Gulsine Ozdemir spent fifteen years turning that objection into an operational framework. A2P2 identifies the governing material behaviour, derives the appropriate activation energy and time equivalence, and translates the result into an experimentally verifiable study design.

The framework has been applied to sterile barrier packaging, single-use bioprocess systems, implantable polymers, adhesives, tubing and industrial membranes. Its predictions have been compared with literature, internal studies and long-duration field service.

Today, Gulsine licenses A2P2 to organisations that want the capability inside their own R&D, quality and regulatory systems. The ambition is larger than faster testing: product-lifetime evidence should be specific to the system being manufactured, reusable across portfolios and defensible under scrutiny.

Built from first principles. Proven through application. Designed for adoption.